Argus upgraded shares of Anheuser-Busch InBev SA/NV (NYSE:BUD – Free Report) from a hold rating to a buy rating in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. Argus currently has $70.00 price target on the consumer goods maker’s stock.
Other research analysts have also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft upgraded Anheuser-Busch InBev SA/NV from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. TD Cowen cut their price target on shares of Anheuser-Busch InBev SA/NV from $65.00 to $55.00 and set a “hold” rating for the company in a report on Wednesday, January 8th. One investment analyst has rated the stock with a hold rating, five have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $66.00.
Check Out Our Latest Stock Analysis on Anheuser-Busch InBev SA/NV
Anheuser-Busch InBev SA/NV Trading Down 0.2 %
Anheuser-Busch InBev SA/NV (NYSE:BUD – Get Free Report) last issued its earnings results on Wednesday, February 26th. The consumer goods maker reported $0.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.75 by $0.13. The business had revenue of $14.84 billion during the quarter, compared to the consensus estimate of $14.07 billion. Anheuser-Busch InBev SA/NV had a return on equity of 15.29% and a net margin of 10.98%. Equities research analysts expect that Anheuser-Busch InBev SA/NV will post 3.37 EPS for the current year.
Institutional Trading of Anheuser-Busch InBev SA/NV
A number of institutional investors have recently bought and sold shares of BUD. Dodge & Cox raised its stake in shares of Anheuser-Busch InBev SA/NV by 27.7% during the 4th quarter. Dodge & Cox now owns 39,996,830 shares of the consumer goods maker’s stock worth $2,002,641,000 after buying an additional 8,670,940 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in Anheuser-Busch InBev SA/NV by 7.2% during the 4th quarter. The Manufacturers Life Insurance Company now owns 7,569,492 shares of the consumer goods maker’s stock valued at $379,004,000 after acquiring an additional 505,206 shares in the last quarter. Holocene Advisors LP raised its position in Anheuser-Busch InBev SA/NV by 22.8% during the third quarter. Holocene Advisors LP now owns 4,331,636 shares of the consumer goods maker’s stock worth $287,144,000 after acquiring an additional 803,257 shares during the last quarter. Capital International Investors lifted its holdings in shares of Anheuser-Busch InBev SA/NV by 5.5% in the fourth quarter. Capital International Investors now owns 2,594,619 shares of the consumer goods maker’s stock valued at $129,201,000 after purchasing an additional 134,243 shares in the last quarter. Finally, Clarkston Capital Partners LLC grew its position in shares of Anheuser-Busch InBev SA/NV by 30.3% in the fourth quarter. Clarkston Capital Partners LLC now owns 1,493,842 shares of the consumer goods maker’s stock valued at $74,797,000 after purchasing an additional 347,000 shares during the last quarter. 5.53% of the stock is currently owned by hedge funds and other institutional investors.
About Anheuser-Busch InBev SA/NV
Anheuser-Busch InBev SA/NV produces, distributes, exports, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands.
Read More
- Five stocks we like better than Anheuser-Busch InBev SA/NV
- The Most Important Warren Buffett Stock for Investors: His Own
- MarketBeat Week in Review – 03/24 – 03/28
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Anheuser-Busch InBev SA/NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anheuser-Busch InBev SA/NV and related companies with MarketBeat.com's FREE daily email newsletter.